State Street Corp Aquestive Therapeutics, Inc. Transaction History
State Street Corp
- $2.59 Trillion
- Q2 2025
A detailed history of State Street Corp transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 1,507,298 shares of AQST stock, worth $5.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,507,298
Previous 1,522,655
1.01%
Holding current value
$5.7 Million
Previous $4.42 Million
13.0%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding AQST
# of Institutions
125Shares Held
47.4MCall Options Held
64.2KPut Options Held
204K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$37.1 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$20.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.33MShares$16.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.98MShares$11.3 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.19MShares$8.28 Million0.32% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $202M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...